Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining eflornithine cream with IPL is more effective for removing unwanted facial hair in women.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

The spironolactone cream did not reduce hair growth in women with hirsutism.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Spironolactone effectively reduces symptoms of hyperandrogenism but has some side effects.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Provenge extends prostate cancer survival by about 4 months.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.